A new ETV6-NTRK3 cell line model reveals MALAT1 as a novel therapeutic target - a short report

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Cellular Oncology

• Publication date

  2018-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s13402-017-0356-2PMID 29119387PMCID PMC12995242
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application

  2016cited by this paper
• Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9

  2016cited by this paper
• Deregulation of polycomb repressor complex 1 modifier AUTS2 in T-cell leukemia

  2016cited by this paper
• NTRK gene fusions as novel targets of cancer therapy across multiple tumour types

  2016cited by this paper
• Predicting genetic interactions from Boolean models of biological networks

  2015cited by this paper
• Malat1 as an evolutionarily conserved lncRNA, plays a positive role in regulating proliferation and maintaining undifferentiated status of early-stage hematopoietic cells

  2015cited by this paper
• Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines

  2015cited by this paper
• MAPK1 up-regulates the expression of MALAT1 to promote the proliferation of cardiomyocytes through PI3K/AKT signaling pathway.

  2015cited by this paper
• Cancer Cytogenetics: Methodology Revisited

  2014cited by this paper
• The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites.

  2014cited by this paper
• Long non-coding RNAs in cancer: implications for personalized therapy

  2014cited by this paper
• TrkC promotes survival and growth of leukemia cells through Akt-mTOR-Dependent Up-Regulation of PLK-1 and Twist-1

  2013cited by this paper
• Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia

  2011cited by this paper
• MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis.

  2011cited by this paper
• Induction of B-Chronic Lymphocytic Leukemia Cell Apoptosis by Arsenic Trioxide Involves Suppression of the Phosphoinositide 3-Kinase/Akt Survival Pathway via c-jun-NH2 Terminal Kinase Activation and PTEN Upregulation

  2010cited by this paper
• Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway

  2009cited by this paper
• Phosphoproteomic analysis identifies the M0-91 cell line as a cellular model for the study of TEL-TRKC fusion-associated leukemia

  2007cited by this paper
• Cytogenetic harvesting of commonly used tumor cell lines

  2007cited by this paper
• ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages.

  2005cited by this paper
• Directing oncogenic fusion genes into stem cells via an SCL enhancer.

  2004cited by this paper
• Acute promyelocytic leukemia cell line AP-1060 established as a cytokine-dependent culture from a patient clinically resistant to all-trans retinoic acid and arsenic trioxide

  2004cited by this paper
• Steady-State Analysis of Genetic Regulatory Networks Modelled by Probabilistic Boolean Networks

  2003cited by this paper
• Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression

  2001cited by this paper
• The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation.

  2001cited by this paper
• Neurotrophin signal transduction in the nervous system.

  2000cited by this paper
• The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells

  2000cited by this paper
• Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease

  1999cited by this paper
• Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25).

  1999cited by this paper
• ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma.

  1998cited by this paper
• A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma

  1998cited by this paper
• Cohabiting t(12;22) and inv(3) primary rearrangements in an acute myelomonocytic leukemia (FAB M4) cell line

  1996cited by this paper
• Cohabiting t(12;22) and inv(3) primary rearrangements in an acute myelomonocytic leukemia (FAB M4) cell line.

  1996cited by this paper
• Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer.

  1988cited by this paper

• Therapeutic Targets and Molecular Mechanisms of Calycosin in the Treatment of Depression: Insights From Chronic Mild Stress Animal Models

  2025cites this paper
• Cancer fusion transcripts with human non-coding RNAs

  2024cites this paper
• Understanding WT1 Alterations and Expression Profiles in Hematological Malignancies

  2023cites this paper
• The Impact of ETV6-NTRK3 Oncogenic Gene Fusions on Molecular and Signaling Pathway Alterations

  2023cites this paper
• Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research

  2023cites this paper
• Glioblastoma treatment slowly moves toward change: novel druggable targets and translational horizons in 2022

  2023cites this paper
• Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020

  2022cites this paper
• Getting Your Laboratory on Track With Neurotrophic Receptor Tyrosine Kinase.

  2022cites this paper
• ETV6-NTRK3 is Associated With Trisomy 8 and Sensitive to TRK Inhibitor in Hematologic Malignancy: Case Report of a Refractory AML and Review of the Literature

  2021cites this paper
• Research progress of long non ⁃ coding RNA involved in arsenic toxicity

  2020cites this paper
• Association of long non-coding RNA and leukemia: a systematic review.

  2020cites this paper
• Sp1-mediated up-regulation of lnc00152 promotes invasion and metastasis of retinoblastoma cells via the miR-30d/SOX9/ZEB2 pathway

  2020cites this paper
• 10 CANCEROLOGIA-TERAPIA ANTINEOPLASTICA AGNOSTICA (PDF).cdr

  2020cites this paper
• Non-coding RNAs in cancers with chromosomal rearrangements: the signatures, causes, functions and implications

  2019cites this paper
• Long Non-coding RNAs in Myeloid Malignancies

  2019cites this paper
• Revisiting NTRKs as an emerging oncogene in hematological malignancies

  2019influential citation
• High level EGFR amplification in a newly established glioblastoma cell line 170-MG-BA.

  2019cites this paper
• The emerging role of lncRNAs in the regulation of cancer stem cells

  2018cites this paper
• NTRK fusion-positive cancers and TRK inhibitor therapy

  2018cites this paper
• Functions and regulatory mechanisms of metastasis‐associated lung adenocarcinoma transcript 1

  2018cites this paper